|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
Q1 FY2011
As of Mar 31, 2011
|
Q4 FY2010
As of Dec 31, 2010
|
Q3 FY2010
As of Sep 30, 2010
|
Q2 FY2010
As of Jun 30, 2010
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Fixed maturity investments, at fair value (amortized cost: $1,927.0 and $1,902.9) | ||||||||||||||||||||
| Equity securities, at fair value (cost: $178.9 and $163.8) | ||||||||||||||||||||
| Other investments (cost: $610.2 and $642.4) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Reinsurance recoverable on unpaid losses | ||||||||||||||||||||
| Reinsurance recoverable on paid losses | ||||||||||||||||||||
| Insurance and reinsurance premiums receivable | ||||||||||||||||||||
| Unearned reinsurance premiums ceded | ||||||||||||||||||||
| Deferred insurance and reinsurance acquisition costs | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Amounts receivable under reverse repurchase agreements | ||||||||||||||||||||
| Unsettled sales of investments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Loss and loss adjustment expense reserves | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Unearned insurance and reinsurance premiums | ||||||||||||||||||||
| Insurance and reinsurance balances payable | ||||||||||||||||||||
| Investment securities sold short, at fair value | ||||||||||||||||||||
| Unsettled purchases of investments | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Amounts payable under repurchase agreements | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Non-cumulative preferred shares ("Preferred Shares") - issued 6,000,000 shares | ||||||||||||||||||||
| Common Shares, at par value - issued 45,113,841 shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Common Shares held in treasury at cost; 1,314,588 and 1,494,717 shares | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated net foreign currency translation losses | ||||||||||||||||||||
| Total Shareholders' Equity available to the Company | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity |
Loading...
